Thursday, November 5, 2026 • 07:07 AM

Transforming Medication Access Through Technology and Human Support

Transforming Medication Access Through Technology and Human Support

A prescription should mark the beginning of treatment, not the start of another obstacle course. Yet for millions of patients, obtaining medication can involve insurance complications, prior authorizations, confusing costs, delayed fulfillment, and uncertainty about what happens next. Even after a prescription is approved, affordability and renewal challenges can interrupt treatment. Gifthealth was founded in 2020 around a simple belief, nothing should stand in the way of better health. The company is rethinking the prescription journey by bringing pharmacy services, medication access, fulfillment, technology, and patient support together in a unified direct-to-patient (DTP) model.

Rather than automating individual tasks within a fragmented structure, Gifthealth focuses on orchestrating the entire prescription journey. Its objective is to improve the measures that matter most, time to treatment, adherence, refill rates, patient experience, and health outcomes. “There are a lot of promises around AI in specialty pharma, but the reality is many solutions are just patching automation around fragmented systems. This is not transformation, it is a sticking plaster,” explains Chip Parkinson, CEO, Gifthealth. Gifthealth's alternative is an integrated platform that connects prescription access, pharmacy fulfillment, and ongoing patient services, helping patients begin treatment sooner and remain on therapy longer.

The need for such an approach is substantial. According to the company, six in ten patients worry about prescription affordability, while four in ten reports not taking medications as prescribed because of cost. Prior authorization creates additional challenges for providers, more than nine in ten physicians report that it has delayed access to necessary care, and more than one in four say it has contributed to a serious adverse event for a patient. Access problems can also persist after the first prescription, with patients experiencing gaps in supply or running out while waiting for renewals. Gifthealth tackles these barriers through a connected system covering access and intake, pharmacy services and fulfillment, and patient support and affordability. Electronic benefits investigation, electronic prior authorization, and simplified enrollment help reduce administrative delays. Automated prescription validation identifies incomplete or incorrect submissions early, while a unified digital pharmacy platform and nationwide partner network support predictable fulfillment.

The company reports a 95 percent dispense rate, compared with a 73 percent national average. For approved prescriptions, it reports an average fulfillment time of 1.4 days, against a 12-day national average. These figures reflect Gifthealth's emphasis on removing friction across the prescription process rather than measuring the success of isolated administrative steps. By connecting access, processing, and dispensing, the company aims to reduce the time between a prescription being written and a patient receiving medication. Affordability is another central component. Gifthealth automatically identifies the lowest available prescription cost for patients and applies available financial assistance. Its digital checkout experience is designed to make medication access simpler and more transparent, while its technology-plus-touch approach ensures patients can receive human assistance when their circumstances require more than automated guidance. The company reports 92 percent treatment persistence, compared with a 60 percent national average. Its approach is built around the understanding that patient support should not begin only after a problem has already disrupted treatment. Instead, assistance is integrated throughout the prescription journey, helping prevent avoidable delays and reducing the likelihood that patients abandon therapy.

Gifthealth combines automation with personalized support to accomplish this. Automated SMS messages and AI-powered voice calls engage patients at points where they may be more likely to discontinue treatment. Physician-approved information helps answer common questions without adding to prescribers' workload. When patients require more complex assistance, live resolution specialists remain available. The company reports that 72 percent of prescriptions are filled without patients needing to contact support. When they do reach out, Gifthealth’s median response time is 40 seconds, with agentic AI supporting every interaction. Customer satisfaction remains above 90 percent, and its reported net promoter score is approximately 9 out of 10.

Scale is central to the model's development. “In fact, we were the first provider to deliver DTP at scale and has served more than seven million patients,” Parkinson adds. The company’s Digi+Hub platform is URAC- and NABP-accredited, engages more than 175,000 prescribers, and is available within 85 percent of electronic health record systems. The platform is licensed in all 50 U.S. states and Puerto Rico, allowing the company to support patient access across a broad geographic footprint.

The acquisition of Occam Health Services strengthened this proposition by creating what Gifthealth describes as a first-of-its-kind digital pharmacy platform and patient access hub. The combination brings together capabilities that traditionally operated separately, enabling pharmaceutical brands to coordinate medication access, fulfillment, and patient services through a more connected solution. For providers, the aim is less administrative work and fewer handoffs; for patients, it is a more consistent experience from prescription to treatment.

Gifthealth's differentiation also rests on recognizing that medication access cannot be solved through technology alone. Specialty medicines and different therapeutic categories bring distinct requirements, and an effective DTP model must account for the challenges associated with each brand, patient population, and treatment pathway. The company emphasizes understanding those dynamics before determining where automation is most useful and when human support is essential.

Looking ahead, Gifthealth is focusing on intentional automation and the use of agentic AI to coordinate workflows rather than simply eliminate manual tasks. Intelligent systems can resolve routine questions at the moment patients need help, identify situations requiring intervention, and recognize when empathy or clinical judgment calls for a human specialist. By automating more routine interactions, the company aims to give its teams greater capacity to support vulnerable patients and those facing complex issues. The broader ambition is to demonstrate that technology can improve both operational efficiency and patient outcomes when it is applied to the right problems. As Parkinson puts it, “technology alone cannot solve the prescription journey.” The future lies in combining integrated systems, real-time information, automation, and human expertise so that assistance arrives when it matters. By rebuilding the prescription journey around those outcomes, Gifthealth is working toward a healthcare experience in which accessing medication becomes less of a barrier and more of a reliable first step toward better health.

Gifthealth

Chip Parkinson, CEO

gifthealth.com

“There are a lot of promises around AI in specialty pharma, but the reality is many solutions are just patching automation around fragmented systems. This is not transformation, it is a sticking plaster”

Magazine
Pharmacy Management Edition 2026
Pharma Business Outlook

Pharma Business Outlook is more than just a publication—it is a bridge that connects pharmaceutical companies, healthcare providers, and key decision-makers. By fostering discussions on regulatory compliance, emerging market opportunities, and digital transformation, the magazine plays a crucial role in shaping the future of the pharmaceutical ecosystem.